Literature DB >> 9933297

HLA typing in the United Kingdom multiple sclerosis genome screen.

F Coraddu1, S Sawcer, R Feakes, J Chataway, S Broadley, H B Jones, D Clayton, J Gray, S Smith, C Taylor, P N Goodfellow, A Compston.   

Abstract

The United Kingdom multiple sclerosis genome screen demonstrated a peak maximum lod score of 2.8 in the HLA region, together with statistically significant excess transmission of the 121-base pair (bp) allele of the tumour necrosis factor-a marker. In order to determine whether this association is independent of the established HLA association, or simply a consequence of the 121-bp allele being part of the same haplotype, we HLA-DR and -DQ typed the 227 sibling-pair families used in the original screen. The expected associations of multiple sclerosis with the DR15 (p=8.7E-18), DQ6 (p=2.0E-09) and DR51 (p=2.8E-16) phenotypes were confirmed, and excess transmission of the DRB1*1501 and DQB1*0602 alleles was demonstrated. Combining HLA typing with the original microsatellite data demonstrated extensive linkage disequilibrium between the 121-bp allele and the 1501-0602 haplotype. Outside this extended haplotype (121-1501-0602), none of the alleles demonstrated significant transmission distortion. Having established the importance of this extended haplotype, we reanalysed the entire genome screen data after excluding those sibling pairs sharing the extended haplotype (n=27). Conditioning the full genome screen data on the basis of identity by state sharing showed that some potential linkage regions identified in the original screen clustered in families, in which the extended haplotype was shared (1p, 2p and 17q), whereas others grouped with those in which it was not (5cen, 7p and Xq). This suggests complexity in the genetics of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9933297     DOI: 10.1007/s100480050048

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  12 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 2.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 3.  New approaches to investigating heterogeneity in complex traits.

Authors:  R Bomprezzi; P E Kovanen; R Martin
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

4.  Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data.

Authors:  Melanie Bahlo; Jim Stankovich; Terence P Speed; Justin P Rubio; Rachel K Burfoot; Simon J Foote
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

5.  Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.

Authors:  René Gödde; Klaus Rohde; Christian Becker; Mahammad R Toliat; Patricia Entz; Anita Suk; Norbert Müller; Eckhart Sindern; Michael Haupts; Sebastian Schimrigk; Peter Nürnberg; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2005-03-16       Impact factor: 4.599

6.  Multiple sclerosis in sibling pairs: an analysis of 250 families.

Authors:  J Chataway; A Mander; N Robertson; S Sawcer; J Deans; M Fraser; S Broadley; D Clayton; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

7.  Brain glioma and human leukocyte antigens (HLA)--is there an association.

Authors:  H K Machulla; F Steinborn; A Schaaf; V Heidecke; N G Rainov
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

8.  Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Helmut Butzkueven; Ingrid A F van Der Mei; Michèle M Sale; Joanne L Dickinson; Patricia Groom; Laura J Johnson; Rex D Simmons; Brian Tait; Mike Varney; Bruce Taylor; Terence Dwyer; Robert Williamson; Nicholas M Gough; Trevor J Kilpatrick; Terence P Speed; Simon J Foote
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

Review 9.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

10.  Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a.

Authors:  Shlomo Flechter; Tirza Klein; Lea Pollak
Journal:  Neurol Int       Date:  2011-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.